Context-specific and immune cell–dependent anti-tumor activities of α1-antitrypsin

α1-antitrypsin (AAT), a circulating glycoprotein that rises during acute phase responses and healthy pregnancies, exhibits immunomodulatory properties in several T-cell–dependent immune pathologies. However, AAT does not interfere with isolated T-cell responses; instead, it facilitates polarization...

Full description

Bibliographic Details
Main Authors: Ofer Guttman, Gabriella Sara Freixo-Lima, Ziv Kaner, Yotam Lior, Peleg Rider, Eli C. Lewis
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00559/full
_version_ 1811265618349916160
author Ofer Guttman
Gabriella Sara Freixo-Lima
Ziv Kaner
Yotam Lior
Peleg Rider
Eli C. Lewis
author_facet Ofer Guttman
Gabriella Sara Freixo-Lima
Ziv Kaner
Yotam Lior
Peleg Rider
Eli C. Lewis
author_sort Ofer Guttman
collection DOAJ
description α1-antitrypsin (AAT), a circulating glycoprotein that rises during acute phase responses and healthy pregnancies, exhibits immunomodulatory properties in several T-cell–dependent immune pathologies. However, AAT does not interfere with isolated T-cell responses; instead, it facilitates polarization of macrophages and dendritic cells towards M2-like and tolerogenic cells, respectively. AAT also allows NK cell responses against tumor cells, while attenuating DC-dependent NK cell activities. Since AAT-treated macrophages bear resemblance to cancer-promoting tumor-associated macrophages (TAMs), it became imperative to examine the possible induction of tumor permissive conditions by AAT. Here, AAT treatment is examined for its effect on tumor development, metastatic spread and selected aspects of tumor immunology. Systemic AAT treatment of mice inoculated with B16-F10 melanoma cells resulted in significant inhibition of tumor growth and metastatic spread. Using NK cell–resistant RMA cells, we show that AAT interferes with tumor development in a CD8+ T-cell–dependent manner. Unexpectedly, upon analysis of tumor cellular composition we identified overly active tumor-infiltrating CD8+ T-cells alongside M1-like TAMs in AAT-treated mice. Based on the ability of AAT to undergo chemical modifications, we emulated conditions of elevated reactive nitrogen and oxygen species. Indeed, macrophages were stimulated by treatment with nitrosylated AAT, and IFN transcripts were significantly elevated in tumors extracted soon after ischemia-reperfusion challenge. These context-specific changes may explain the differential effects of AAT on immune responses towards tumor cells versus benign antigenic targets. These data suggest that systemically elevated levels of AAT may accommodate its physiological function in inflammatory resolution, without compromising tumor-targeting immune responses.
first_indexed 2024-04-12T20:27:08Z
format Article
id doaj.art-424d9020d321405794983a8a30fd8d72
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T20:27:08Z
publishDate 2016-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-424d9020d321405794983a8a30fd8d722022-12-22T03:17:51ZengFrontiers Media S.A.Frontiers in Immunology1664-32242016-12-01710.3389/fimmu.2016.00559229198Context-specific and immune cell–dependent anti-tumor activities of α1-antitrypsinOfer Guttman0Gabriella Sara Freixo-Lima1Ziv Kaner2Yotam Lior3Peleg Rider4Eli C. Lewis5Ben-Gurion UniversityBen-Gurion UniversityBen-Gurion UniversityBen-Gurion UniversityBen-Gurion UniversityBen-Gurion Universityα1-antitrypsin (AAT), a circulating glycoprotein that rises during acute phase responses and healthy pregnancies, exhibits immunomodulatory properties in several T-cell–dependent immune pathologies. However, AAT does not interfere with isolated T-cell responses; instead, it facilitates polarization of macrophages and dendritic cells towards M2-like and tolerogenic cells, respectively. AAT also allows NK cell responses against tumor cells, while attenuating DC-dependent NK cell activities. Since AAT-treated macrophages bear resemblance to cancer-promoting tumor-associated macrophages (TAMs), it became imperative to examine the possible induction of tumor permissive conditions by AAT. Here, AAT treatment is examined for its effect on tumor development, metastatic spread and selected aspects of tumor immunology. Systemic AAT treatment of mice inoculated with B16-F10 melanoma cells resulted in significant inhibition of tumor growth and metastatic spread. Using NK cell–resistant RMA cells, we show that AAT interferes with tumor development in a CD8+ T-cell–dependent manner. Unexpectedly, upon analysis of tumor cellular composition we identified overly active tumor-infiltrating CD8+ T-cells alongside M1-like TAMs in AAT-treated mice. Based on the ability of AAT to undergo chemical modifications, we emulated conditions of elevated reactive nitrogen and oxygen species. Indeed, macrophages were stimulated by treatment with nitrosylated AAT, and IFN transcripts were significantly elevated in tumors extracted soon after ischemia-reperfusion challenge. These context-specific changes may explain the differential effects of AAT on immune responses towards tumor cells versus benign antigenic targets. These data suggest that systemically elevated levels of AAT may accommodate its physiological function in inflammatory resolution, without compromising tumor-targeting immune responses.http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00559/fullCD8-Positive T-LymphocytesReactive Oxygen Speciesnitrosylationtumor immunologytumor associated macrophages
spellingShingle Ofer Guttman
Gabriella Sara Freixo-Lima
Ziv Kaner
Yotam Lior
Peleg Rider
Eli C. Lewis
Context-specific and immune cell–dependent anti-tumor activities of α1-antitrypsin
Frontiers in Immunology
CD8-Positive T-Lymphocytes
Reactive Oxygen Species
nitrosylation
tumor immunology
tumor associated macrophages
title Context-specific and immune cell–dependent anti-tumor activities of α1-antitrypsin
title_full Context-specific and immune cell–dependent anti-tumor activities of α1-antitrypsin
title_fullStr Context-specific and immune cell–dependent anti-tumor activities of α1-antitrypsin
title_full_unstemmed Context-specific and immune cell–dependent anti-tumor activities of α1-antitrypsin
title_short Context-specific and immune cell–dependent anti-tumor activities of α1-antitrypsin
title_sort context specific and immune cell dependent anti tumor activities of α1 antitrypsin
topic CD8-Positive T-Lymphocytes
Reactive Oxygen Species
nitrosylation
tumor immunology
tumor associated macrophages
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00559/full
work_keys_str_mv AT oferguttman contextspecificandimmunecelldependentantitumoractivitiesofa1antitrypsin
AT gabriellasarafreixolima contextspecificandimmunecelldependentantitumoractivitiesofa1antitrypsin
AT zivkaner contextspecificandimmunecelldependentantitumoractivitiesofa1antitrypsin
AT yotamlior contextspecificandimmunecelldependentantitumoractivitiesofa1antitrypsin
AT pelegrider contextspecificandimmunecelldependentantitumoractivitiesofa1antitrypsin
AT eliclewis contextspecificandimmunecelldependentantitumoractivitiesofa1antitrypsin